Hepatitis C Virus Entry
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
The lipid droplet is an important organelle for hepatitis C virus production
Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Wakita, T., Hijikata, M., & Shimotohno, K. (2007) · Nature Cell Biology · doi:10.1038/ncb1631 · Cited by 1,249
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wölk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D., & Rice, C. M. (2007) · Nature · doi:10.1038/nature05654 · Cited by 1,232
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Bartosch, B., Dubuisson, J., & Cosset, F.-L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021756 · Cited by 1,111
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
Agnello, V., Ábel, G., Elfahal, M., Knight, G. B., & Zhang, Q.-X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12766 · Cited by 974
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P., & Rice, C. M. (2009) · Nature · doi:10.1038/nature07684 · Cited by 941
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M., & McKeating, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832180100 · Cited by 795
Lupberger, J., Zeisel, M. B., Xiao, F., Thumann, C., Fofana, I., Zona, L., Davis, C., Mee, C. J., Turek, M., Gorke, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2341 · Cited by 706
Self-citationCharacterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
Bartosch, B., Vitelli, A., Granier, C., Goujon, C., Dubuisson, J., Pascale, S., Scarselli, E., Cortese, R., Nicosia, A., & Cosset, F.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305289200 · Cited by 631
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., & Rouillé, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00024-06 · Cited by 599
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Law, M., Maruyama, T., Lewis, J., Giang, E., Tarr, A. W., Stamataki, Z., Gastaminza, P., Chisari, F. V., Jones, I. M., Fox, R. I., et al. (2008) · Nature Medicine · doi:10.1038/nm1698 · Cited by 591
Huang, H., Sun, F., Owen, D. M., Li, W., Chen, Y., Gale, M., & Ye, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700760104 · Cited by 533
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
Barth, H., Schäfer, C., Adah, M. I., Zhang, F., Linhardt, R. J., Toyoda, H., Kinoshita-Toyoda, A., Toida, T., van Kuppevelt, T. H., Depla, E., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302267200 · Cited by 500
Self-citationFlint, M., Maidens, C., Loomis-Price, L. D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S., & McKeating, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6235-6244.1999 · Cited by 469
Appel, N., Zayas, M., Miller, S., Krijnse-Locker, J., Schaller, T., Friebe, P., Kallis, S., Engel, U., & Bartenschlager, R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000035 · Cited by 466
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion
Gastaminza, P., Cheng, G., Wieland, S., Zhong, J., Liao, W., & Chisari, F. V. (2008) · Journal of Virology · doi:10.1128/jvi.02053-07 · Cited by 463
Sainz, B., Barretto, N., Martin, D. N., Hiraga, N., Imamura, M., Hussain, S., Marsh, K. A., Yu, X., Chayama, K., Alrefai, W. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2581 · Cited by 452
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
Lindenbach, B. D., Meuleman, P., Ploss, A., Vanwolleghem, T., Syder, A. J., McKeating, J. A., Lanford, R. E., Feinstone, S. M., Major, M. E., Leroux-Roels, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511218103 · Cited by 448
Chang, K.-S., Jiang, J., Cai, Z., & Luo, G. (2007) · Journal of Virology · doi:10.1128/jvi.01091-07 · Cited by 424
Koutsoudakis, G., Kaul, A., Steinmann, E., Kallis, S., Lohmann, V., Pietschmann, T., & Bartenschlager, R. (2006) · Journal of Virology · doi:10.1128/jvi.02460-05 · Cited by 414
Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
Boriskin, Y., Leneva, I., Pecheur, E.-I., & Polyak, S. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784049658 · Cited by 410
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
Packard, C. J., & Shepherd, J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.12.3542 · Cited by 402
Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells
Baumert, T. F., Ito, S., Wong, D. T., & Liang, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3827-3836.1998 · Cited by 397
Self-citationHepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
Pöhlmann, S., Zhang, J., Baribaud, F., Chen, Z., Leslie, G. J., Lin, G., Granelli-Piperno, A., Doms, R. W., Rice, C. M., & McKeating, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4070-4080.2003 · Cited by 389
Timpe, J. M., Stamataki, Z., Jennings, A., Hu, K., Farquhar, M. J., Harris, H. J., Schwarz, A., Desombere, I., Roels, G. L., Balfe, P., et al. (2008) · Hepatology · doi:10.1002/hep.21959 · Cited by 389
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
Tscherne, D. M., Jones, C. T., Evans, M. J., Lindenbach, B. D., McKeating, J. A., & Rice, C. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1734-1741.2006 · Cited by 380
A genetically humanized mouse model for hepatitis C virus infection
Dorner, M., Horwitz, J. A., Robbins, J. B., Barry, W. T., Feng, Q., Mu, K., Jones, C. T., Schoggins, J. W., Catanese, M. T., Burton, D. R., et al. (2011) · Nature · doi:10.1038/nature10168 · Cited by 378
DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2
Lozach, P.-Y., Lortat-Jacob, H., De Lacroix De Lavalette, A., Staropoli, I., Foung, S., Amara, A., Houlès, C., Fieschi, F., Schwartz, O., Virelizier, J.-L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301284200 · Cited by 375
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes
Hijikata, M., Shimizu, Y. K., Kato, H., Iwamoto, A., Shih, J. W., Alter, H. J., Purcell, R. H., & Yoshikura, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1953-1958.1993 · Cited by 373
Association of hepatitis C virus in human sera with ?-lipoprotein
Thomssen, R., Bonk, S., Propfe, C., Heermann, K.-H., K�chel, H. G., & Uy, A. (1992) · Medical Microbiology and Immunology · doi:10.1007/bf00198849 · Cited by 366
Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
Jia, L., Betters, J. L., & Yu, L. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142233 · Cited by 356
Merz, A., Long, G., Hiet, M.-S., Brügger, B., Chlanda, P., Andre, P., Wieland, F., Krijnse-Locker, J., & Bartenschlager, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175018 · Cited by 356
Liu, S., Yang, W., Shen, L., Turner, J. R., Coyne, C. B., & Wang, T. (2009) · Journal of Virology · doi:10.1128/jvi.01888-08 · Cited by 352
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus
Monazahian, M., B�hme, I., Bonk, S., Koch, A., Scholz, C., Grethe, S., & Thomssen, R. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199903)57:3<223::aid-jmv2>3.0.co;2-4 · Cited by 349
Nielsen, S. U., Bassendine, M. F., Burt, A. D., Martin, C., Pumeechockchai, W., & Toms, G. L. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2418-2428.2006 · Cited by 347
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
Giang, E., Dorner, M., Prentoe, J. C., Dreux, M., Evans, M. J., Bukh, J., Rice, C. M., Ploss, A., Burton, D. R., & Law, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114927109 · Cited by 346
High-density lipoprotein heterogeneity and function in reverse cholesterol transport
Rothblat, G. H., & Phillips, M. C. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328338472d · Cited by 340
The metabolism and anti-atherogenic properties of HDL
Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800034-jlr200 · Cited by 331
Koh, C., Li, Q., & Liang, J. (2016) · Clinical Virology · doi:10.1128/9781555819439.ch54 · Cited by 321
Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
Pawlotsky, J.-M. (2011) · Hepatology · doi:10.1002/hep.24262 · Cited by 311
Very-low-density lipoprotein assembly and secretion
Shelness, G. S., & Sellers, J. A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00008 · Cited by 309
Meertens, L., Bertaux, C., & Dragic, T. (2006) · Journal of Virology · doi:10.1128/jvi.01717-06 · Cited by 308
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus
Gardner, J. P., Durso, R. J., Arrigale, R. R., Donovan, G. P., Maddon, P. J., Dragic, T., & Olson, W. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831128100 · Cited by 306
Bartosch, B., Verney, G., Dreux, M., Donot, P., Morice, Y., Penin, F., Pawlotsky, J.-M., Lavillette, D., & Cosset, F.-L. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8217-8229.2005 · Cited by 290
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288
Boulant, S., Targett-Adams, P., & McLauchlan, J. (2007) · Journal of General Virology · doi:10.1099/vir.0.82898-0 · Cited by 274
Kapadia, S. B., Barth, H., Baumert, T., McKeating, J. A., & Chisari, F. V. (2007) · Journal of Virology · doi:10.1128/jvi.01134-06 · Cited by 271
Self-citationZeisel, M. B., Koutsoudakis, G., Schnober, E. K., Haberstroh, A., Blum, H. E., Cosset, F.-L., Wakita, T., Jaeck, D., Doffoel, M., Royer, C., et al. (2007) · Hepatology · doi:10.1002/hep.21994 · Cited by 260
Self-citationNeutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
Brimacombe, C. L., Grove, J., Meredith, L. W., Hu, K., Syder, A. J., Flores, M. V., Timpe, J. M., Krieger, S. E., Baumert, T. F., Tellinghuisen, T. L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.01592-10 · Cited by 256
Self-citationApolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
Jiang, J., & Luo, G. (2009) · Journal of Virology · doi:10.1128/jvi.01476-09 · Cited by 255
Voisset, C., Callens, N., Blanchard, E., Beeck, A. O. D., Dubuisson, J., & Vu‐Dac, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411600200 · Cited by 253
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
Frey, S. E., Houghton, M., Coates, S., Abrignani, S., Chien, D., Rosa, D., Pileri, P., Ray, R., Di Bisceglie, A. M., Rinella, P., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.084 · Cited by 251
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
Jones, C. T., Catanese, M. T., Law, L. M. J., Khetani, S. R., Syder, A. J., Ploss, A., Oh, T. S., Schoggins, J. W., MacDonald, M. R., Bhatia, S. N., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1604 · Cited by 249
Dreux, M., Pietschmann, T., Granier, C., Voisset, C., Ricard‐Blum, S., Mangeot, P.-E., Keck, Z., Foung, S. K. H., Vu‐Dac, N., Dubuisson, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602706200 · Cited by 246
Polyak, S. J., Morishima, C., Shuhart, M. C., Wang, C. C., Liu, Y., & Lee, D. Y. –. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.038 · Cited by 242
Gastaminza, P., Kapadia, S. B., & Chisari, F. V. (2006) · Journal of Virology · doi:10.1128/jvi.01150-06 · Cited by 241
Claudin Association with CD81 Defines Hepatitis C Virus Entry
Harris, H. J., Davis, C., Mullins, J. G. L., Hu, K., Goodall, M., Farquhar, M. J., Mee, C. J., McCaffrey, K., Young, S., Drummer, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.104836 · Cited by 237
Benga, W. J. A., Krieger, S. E., Dimitrova, M., Zeisel, M. B., Parnot, M., Lupberger, J., Hildt, E., Luo, G., McLauchlan, J., Baumert, T. F., et al. (2010) · Hepatology · doi:10.1002/hep.23278 · Cited by 234
Self-citationOwen, D. M., Huang, H., Ye, J., & Gale, M. (2009) · Virology · doi:10.1016/j.virol.2009.08.037 · Cited by 234
THOMSSEN, R., Bonk, S., & Thiele, A. (1993) · Medical Microbiology and Immunology · doi:10.1007/bf00191948 · Cited by 234
Multiple Effects of Silymarin on the Hepatitis C Virus Lifecycle
Wagoner, J., Negash, A., Kane, O. J., Martinez, L. E., Nahmias, Y., Bourne, N., Owen, D. M., Grove, J., Brimacombe, C., McKeating, J. A., et al. (2010) · Hepatology · doi:10.1002/hep.23587 · Cited by 232
Claudin-6 and Claudin-9 Function as Additional Coreceptors for Hepatitis C Virus
Zheng, A., Yuan, F., Li, Y., Zhu, F., Hou, P., Li, J., Song, X., Ding, M., & Deng, H. (2007) · Journal of Virology · doi:10.1128/jvi.01457-07 · Cited by 224
Wünschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N., & Stapleton, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10055-10062.2000 · Cited by 222
CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry
Harris, H. J., Farquhar, M. J., Mee, C. J., Davis, C., Reynolds, G. M., Jennings, A., Hu, K., Yuan, F., Deng, H., Hubscher, S. G., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02286-07 · Cited by 221
Bankwitz, D., Steinmann, E., Bitzegeio, J., Ciesek, S., Friesland, M., Herrmann, E. M., Zeisel, M. B., Baumert, T. F., Keck, Z., Foung, S. K. H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02200-09 · Cited by 221
Self-citationL-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus
Cormier, E. G., Durso, R. J., Tsamis, F., Boussemart, L., Manix, C., Olson, W. C., Gardner, J. P., & Dragic, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405695101 · Cited by 210
Lozach, P.-Y., Amara, A., Bartosch, B., Virelizier, J.-L., Arenzana-Seisdedos, F., Cosset, F.-L., & Altmeyer, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402296200 · Cited by 205
Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection
Aizaki, H., Morikawa, K., Fukasawa, M., Hara, H., Inoue, Y., Tani, H., Saito, K., Nishijima, M., Hanada, K., Matsuura, Y., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02530-07 · Cited by 196
Krieger, S. E., Zeisel, M. B., Davis, C., Thumann, C., Harris, H. J., Schnober, E. K., Mee, C., Soulier, E., Royer, C., Lambotin, M., et al. (2010) · Hepatology · doi:10.1002/hep.23445 · Cited by 192
Self-citationViral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction
Barth, H., Schnober, E. K., Zhang, F., Linhardt, R. J., Depla, E., Boson, B., Cosset, F.-L., Patel, A. H., Blum, H. E., & Baumert, T. F. (2006) · Journal of Virology · doi:10.1128/jvi.00941-06 · Cited by 192
Self-citationCD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
Witteveldt, J., Evans, M. J., Bitzegeio, J., Koutsoudakis, G., Owsianka, A. M., Angus, A. G. N., Keck, Z.-Y., Foung, S. K. H., Pietschmann, T., Rice, C. M., et al. (2009) · Journal of General Virology · doi:10.1099/vir.0.006700-0 · Cited by 190
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
Coller, K. E., Berger, K. L., Heaton, N. S., Cooper, J. D., Yoon, R., & Randall, G. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000702 · Cited by 188
Lavillette, D., Pécheur, E.-I., Donot, P., Fresquet, J., Molle, J., Corbau, R., Dreux, M., Penin, F., & Cosset, F.-L. (2007) · Journal of Virology · doi:10.1128/jvi.02642-06 · Cited by 187
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
Zeisel, M. B., Fofana, I., Fafi-Kremer, S., & Baumert, T. F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.014 · Cited by 184
Self-citationApolipoprotein C1 Association with Hepatitis C Virus
Meunier, J., Russell, R. S., Engle, R. E., Faulk, K. N., Purcell, R. H., & Emerson, S. U. (2008) · Journal of Virology · doi:10.1128/jvi.00914-08 · Cited by 180
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
Houghton, M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00977.x · Cited by 177
Role of low-density lipoprotein receptor in the hepatitis C virus life cycle
Albecka, A., Belouzard, S., de Beeck, A. O., Descamps, V., Goueslain, L., Bertrand-Michel, J., Tercé, F., Duverlie, G., Rouillé, Y., & Dubuisson, J. (2012) · Hepatology · doi:10.1002/hep.25501 · Cited by 176
Fofana, I., Krieger, S. E., Grunert, F., Glauben, S., Xiao, F., Fafi–Kremer, S., Soulier, E., Royer, C., Thumann, C., Mee, C. J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.073 · Cited by 176
Self-citationCyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans
Helle, F., Wychowski, C., Vu-Dac, N., Gustafson, K. R., Voisset, C., & Dubuisson, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602431200 · Cited by 175
Hepatitis C Virus Attachment Mediated by Apolipoprotein E Binding to Cell Surface Heparan Sulfate
Jiang, J., Cun, W., Wu, X., Shi, Q., Tang, H., & Luo, G. (2012) · Journal of Virology · doi:10.1128/jvi.07222-11 · Cited by 171
Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes
Lavillette, D., Bartosch, B., Nourrisson, D., Verney, G., Cosset, F., Pénin, F., & Pécheur, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509747200 · Cited by 171
Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease
Bukh, J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.016 · Cited by 168
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Syder, A. J., Lee, H., Zeisel, M. B., Grove, J., Soulier, E., Macdonald, J. E., Chow, S., Chang, J. Y., Baumert, T. F., McKeating, J. A., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.024 · Cited by 167
Self-citationBenedicto, I., Molina-Jiménez, F., Bartosch, B., Cosset, F.-L., Lavillette, D., Prieto, J., Moreno-Otero, R., Valenzuela-Fernández, A., Aldabe, R., López-Cabrera, M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00038-09 · Cited by 165
Hepatitis C virus: Buoyant density if the factor VIII‐derived isolate in sucrose
Bradley, D., McCaustland, K., Krawczynski, K., Spelbring, J., Humphey, C., & Cook, E. H. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890340315 · Cited by 165
Saunier, B., Triyatni, M., Ulianich, L., Maruvada, P., Yen, P. M., & Kohn, L. D. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.546-559.2003 · Cited by 161
Griffithsin Has Antiviral Activity against Hepatitis C Virus
Meuleman, P., Albecka, A., Belouzard, S., Vercauteren, K., Verhoye, L., Wychowski, C., Leroux-Roels, G., Palmer, K. E., & Dubuisson, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-11 · Cited by 160
Catanese, M. T., Graziani, R., von Hahn, T., Moreau, M., Huby, T., Paonessa, G., Santini, C., Luzzago, A., Rice, C. M., Cortese, R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00193-07 · Cited by 160
Altmann, S. W., Davis, H. R., Yao, X., Laverty, M., Compton, D. S., Zhu, L.-J., Crona, J. H., Caplen, M. A., Hoos, L. M., Tetzloff, G., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00190-1 · Cited by 158
Maillard, P., Huby, T., Andréo, U., Moreau, M., Chapman, J., & Budkowska, A. (2006) · The FASEB Journal · doi:10.1096/fj.05-4728fje · Cited by 158
Meuleman, P., Catanese, M. T., Verhoye, L., Desombere, I., Farhoudi, A., Jones, C. T., Sheahan, T. P., Grzyb, K., Cortese, R., Rice, C. M., et al. (2011) · Hepatology · doi:10.1002/hep.24692 · Cited by 158
Garrone, P., Fluckiger, A.-C., Mangeot, P. E., Gauthier, E., Dupeyrot-Lacas, P., Mancip, J., Cangialosi, A., du Chéné, I., Grand, R. L., Mangeot, I., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002330 · Cited by 156
Cell entry of hepatitis C virus
Bartosch, B., & Cosset, F. (2006) · Virology · doi:10.1016/j.virol.2005.12.027 · Cited by 155
Trotard, M., Lepère-Douard, C., Régeard, M., Piquet-Pellorce, C., Lavillette, D., Cosset, F.-L., Gripon, P., & Le Seyec, J. (2009) · The FASEB Journal · doi:10.1096/fj.09-131920 · Cited by 153
Vanwolleghem, T., Bukh, J., Meuleman, P., Desombere, I., Meunier, J., Alter, H. J., Purcell, R. H., & Leroux-Roels, G. G. (2008) · Hepatology · doi:10.1002/hep.22244 · Cited by 153
Cun, W., Jiang, J., & Luo, G. G. (2010) · Journal of Virology · doi:10.1128/jvi.01021-10 · Cited by 149
Hepatitis C virus entry: Molecular biology and clinical implications
Barth, H., Liang, J. T., & Baumert, T. F. (2006) · Hepatology · doi:10.1002/hep.21321 · Cited by 149
Self-citationHepatitis C Virus Induces CD81 and Claudin-1 Endocytosis
Farquhar, M. J., Hu, K., Harris, H. J., Davis, C., Brimacombe, C. L., Fletcher, S. J., Baumert, T. F., Rappoport, J. Z., Balfe, P., & McKeating, J. A. (2012) · Journal of Virology · doi:10.1128/jvi.06996-11 · Cited by 148
Self-citationPrentoe, J. C., Jensen, T. B., Meuleman, P., Serre, S. B. N., Scheel, T. K. H., Leroux-Roels, G. G., Gottwein, J. M., & Bukh, J. (2010) · Journal of Virology · doi:10.1128/jvi.01594-10 · Cited by 147
Hepatitis C Virus Targets DC-SIGN and L-SIGN To Escape Lysosomal Degradation
Ludwig, I. S., Lekkerkerker, A. N., Depla, E., Bosman, F., Musters, R. J. P., Depraetere, S., van Kooyk, Y., & Geijtenbeek, T. B. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8322-8332.2004 · Cited by 145
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
Tscherne, D. M., Evans, M. J., von Hahn, T., Jones, C. T., Stamataki, Z., McKeating, J. A., Lindenbach, B. D., & Rice, C. M. (2007) · Journal of Virology · doi:10.1128/jvi.01748-06 · Cited by 145
Fafi-Kremer, S., Fofana, I., Soulier, E., Carolla, P., Meuleman, P., Leroux-Roels, G., Patel, A. H., Cosset, F.-L., Pessaux, P., Doffoël, M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090766 · Cited by 142
Self-citationHawke, R. L., Schrieber, S. J., Soule, T. A., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347475 · Cited by 142
Vaccination for hepatitis C virus: closing in on an evasive target
Halliday, J., Klenerman, P., & Barnes, E. J. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.55 · Cited by 140
Infectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms
Hishiki, T., Shimizu, Y., Tobita, R., Sugiyama, K., Ogawa, K., Funami, K., Ohsaki, Y., Fujimoto, T., Takaku, H., Wakita, T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01063-10 · Cited by 138
Self-citationPolarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
Mee, C. J., Harris, H. J., Farquhar, M. J., Wilson, G., Reynolds, G., Davis, C., van IJzendoorn, S. C. D., Balfe, P., & McKeating, J. A. (2009) · Journal of Virology · doi:10.1128/jvi.00246-09 · Cited by 137
Dreux, M., Dao Thi, V. L., Fresquet, J., Guérin, M., Julia, Z., Verney, G., Durantel, D., Zoulim, F., Lavillette, D., Cosset, F.-L., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000310 · Cited by 134
Thi, V. L. D., Granier, C., Zeisel, M. B., Guérin, M., Mancip, J., Granio, O., Pénin, F., Lavillette, D., Bartenschlager, R. F. W., Baumert, T. F., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365924 · Cited by 134
Self-citationOxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
von Hahn, T., Lindenbach, B. D., Boullier, A., Quehenberger, O., Paulson, M. S., Rice, C. M., & McKeating, J. A. (2006) · Hepatology · doi:10.1002/hep.21139 · Cited by 134
Out, R., Hoekstra, M., Spijkers, J. A. A., Kruijt, J. K., van Eck, M., Bos, I. S. T., Twisk, J., & Van Berkel, T. J. C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400191-jlr200 · Cited by 133
Benedicto, I., Molina‐Jiménez, F., Barreiro, O., Maldonado-Rodríguez, A., Prìeto, J., Moreno‐Otero, R., Aldabe, R., López‐Cabrera, M., & Majano, P. L. (2008) · Hepatology · doi:10.1002/hep.22465 · Cited by 133
Assembly of a Functional HCV Glycoprotein Heterodimer
Lavie, M., Goffard, A., & Dubuisson, J. (2007) · Current Issues in Molecular Biology · doi:10.21775/cimb.009.071 · Cited by 120
von Hahn, T., & Rice, C. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700024200 · Cited by 117
Yang, W. Z., Qiu, C., Biswas, N., Jin, J., Watkins, S. C., Montelaro, R. C., Coyne, C. B., & Wang, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709824200 · Cited by 115
Zeisel, M., Lupberger, J., Fofana, I., & Baumert, T. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.022 · Cited by 114
Self-citationHepatitis C virus receptor expression in normal and diseased liver tissue
Reynolds, G. M., Harris, H. J., Jennings, A., Hu, K., Grove, J., Lalor, P. F., Adams, D. H., Balfe, P., Hübscher, S. G., & McKeating, J. A. (2008) · Hepatology · doi:10.1002/hep.22028 · Cited by 112
Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity
Farquhar, M. J., Harris, H. J., Diskar, M., Jones, S., Mee, C., Nielsen, S. U., Brimacombe, C. L., Molina, S., Toms, G. L., Maurel, P., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00592-08 · Cited by 112
The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus
Dreux, M., Boson, B., Ricard‐Blum, S., Molle, J., Lavillette, D., Bartosch, B., Pécheur, E., & Cosset, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705358200 · Cited by 107
Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry
Bertaux, C., & Dragic, T. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4940-4948.2006 · Cited by 104
Mazumdar, B., Banerjee, A. K., Meyer, K., & Ray, R. (2011) · Hepatology · doi:10.1002/hep.24523 · Cited by 103
Barth, H., Schnober, E. K., Neumann‐Haefelin, C., Thumann, C., Zeisel, M. B., Diepolder, H. M., Hu, Z., Liang, T. J., Blum, H. E., Thimme, R., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02478-07 · Cited by 102
Self-citationApolipoprotein ε3 allele is associated with persistent hepatitis C virus infection
Price, D. A., Bassendine, M. F., Norris, S. M., Golding, C., Toms, G. L., Schmid, M. L., Morris, C. M., Burt, A. D., & Donaldson, P. T. (2006) · Gut · doi:10.1136/gut.2005.079905 · Cited by 94
Characterization of the Heparin Binding Sites in Human Apolipoprotein E
Saito, H., Dhanasekaran, P., Nguyen, D., Baldwin, F., Weisgraber, K. H., Wehrli, S., Phillips, M. C., & Lund-Katz, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213207200 · Cited by 90
Zahid, M., Turek, M., Xiao, F., Thi, V. L. D., Guérin, M., Fofana, I., Bachellier, P., Thompson, J., Delang, L., Neyts, J. H., et al. (2012) · Hepatology · doi:10.1002/hep.26097 · Cited by 89
Self-citationCukierman, L., Meertens, L., Bertaux, C., Kajumo, F., & Dragic, T. (2009) · Journal of Virology · doi:10.1128/jvi.02262-08 · Cited by 89
Wang, H., Gilham, D., & Lehner, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706841200 · Cited by 88
Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection
Andréo, U., Maillard, P., Kalinina, O., Walic, M., MEURS, E. F., Martinot-Peignoux, M., Marcellin, P., & Budkowska, A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00972.x · Cited by 88
Steinmann, D., Barth, H., Gissler, B., Schürmann, P., Adah, M. I., Gerlach, J. T., Pape, G. R., Depla, E., Jacobs, D., Maertens, G. G., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9030-9040.2004 · Cited by 86
Self-citationVoisset, C., Lavie, M., Helle, F., et al. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01070.x · Cited by 83
The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles
Morikawa, K., Zhao, Z., Date, T., Miyamoto, M., Murayama, A., Akazawa, D., Tanabe, J., Sone, S., & Wakita, T. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20842 · Cited by 83
Scavenger Receptor Class B Type I and Hepatitis C Virus Infection of PrimaryTupaiaHepatocytes
Barth, H., Cerino, R., Arcuri, M., Hoffmann, M., Schürmann, P., Adah, M. I., Gissler, B., Zhao, X., Ghisetti, V., Lavezzo, B., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5774-5785.2005 · Cited by 83
Self-citationJamil, H., Chu, C.-H., Dickson, J. K., Chen, Y., Yan, M., Biller, S. A., Gregg, R. E., Wetterau, J. R., & Gordon, D. A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32526-8 · Cited by 81
Felmlee, D. J., Sheridan, D. A., Bridge, S. H., Nielsen, S. U., Milne, R. W., Packard, C. J., CASLAKE, M. J., McLauchlan, J., Toms, G. L., Neely, R. D. G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.047 · Cited by 79
Self-citationHuman apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding
Liu, S., McCormick, K. D., Zhao, W., Zhao, T., Fan, D., & Wang, T. (2012) · Hepatology · doi:10.1002/hep.25665 · Cited by 73
Turning Hepatitis C into a Real Virus
Murray, C. L., & Rice, C. M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102954 · Cited by 70
Small molecule inhibition of hepatitis C virus E2 binding to CD81
VanCompernolle, S. E., Wiznycia, A. V., Rush, J. R., Dhanasekaran, M., Baures, P. W., & Todd, S. C. (2003) · Virology · doi:10.1016/s0042-6822(03)00406-9 · Cited by 66
Caveolin-1 Is Not Required for Murine Intestinal Cholesterol Transport
Valasek, M. A., Weng, J., Shaul, P. W., Anderson, R. G. W., & Repa, J. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504609200 · Cited by 65
Roingeard, P., Hourioux, C., Blanchard, E., & Prensier, G. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0447-2 · Cited by 64
Topology of hepatitis C virus envelope glycoproteins
Beeck, A. O. D., & Dubuisson, J. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.391 · Cited by 61
Lipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry
Maillard, P., Walic, M., Meuleman, P., Roohvand, F., Huby, T., Goff, W. L., Leroux-Roels, G. G., Pécheur, E., & Budkowska, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026637 · Cited by 58
Functional Analysis of Hepatitis C Virus Envelope Proteins, Using a Cell-Cell Fusion Assay
Kobayashi, M., Bennett, M. C., Bercot, T., & Singh, I. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1817-1825.2006 · Cited by 54
Zheng, C., Khoo, C., Furtado, J., Ikewaki, K., & Sacks, F. M. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.2.272 · Cited by 49
Changes in mitochondrial surface charge mediate recruitment of signaling molecules during apoptosis
Heit, B., Yeung, T., & Grinstein, S. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2010 · Cited by 40
Yamamoto, M., Aizaki, H., Fukasawa, M., Teraoka, T., Miyamura, T., Wakita, T., & Suzuki, T. (2011) · Journal of General Virology · doi:10.1099/vir.0.032391-0 · Cited by 26
Bridge, S. H., Sheridan, D. A., Felmlee, D. J., Nielsen, S. U., Thomas, H. C., Taylor-Robinson, S. D., Neely, R. D. G., Toms, G. L., & Bassendine, M. F. (2010) · Gut · doi:10.1136/gut.2010.222133 · Cited by 24
Self-citationSkov, M., Tønnesen, C. K., Hansen, G. H., & Danielsen, E. M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00344.2010 · Cited by 22
Cited by
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
Pawlotsky, J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.003 · Cited by 518
Manns, M. P., Buti, M., Gane, E., Pawlotsky, J.-M., Razavi, H., Terrault, N., & Younossi, Z. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.6 · Cited by 506
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
Bartenschlager, R., Lohmann, V., & Penin, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3046 · Cited by 402
Tight junction proteins in gastrointestinal and liver disease
Zeisel, M. B., Dhawan, P., & Baumert, T. F. (2019) · Gut · doi:10.1136/gutjnl-2018-316906 · Cited by 358
Self-citationKoh, C., Li, Q., & Liang, J. (2016) · Clinical Virology · doi:10.1128/9781555819439.ch54 · Cited by 321
Metadata
- Authors
- Zeisel, M. B., Felmlee, D. J., & Baumert, T. F.
- Venue
- Current Topics in Microbiology and Immunology
- Publisher
- Springer Berlin Heidelberg
- Published
- 2013
- Volume
- 369
- Pages
- 87-112
- ISSN
- 0070-217X (ISSN-L)
- 2196-9965
- OpenAlex
- W2162484862
- Cited by
- 179
- References
- 150
- FWCI
- 45.81
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.